These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 11090072)
21. Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms. Nakajima J; Takamoto S; Oka T; Tanaka M; Takeuchi E; Murakawa T Eur J Cardiothorac Surg; 2000 Sep; 18(3):287-92. PubMed ID: 10973537 [TBL] [Abstract][Full Text] [Related]
22. Metaplastic thymoma with myasthenia gravis presumably caused by an accumulation of intratumoral immature T cells: a case report. Tajima S; Yanagiya M; Sato M; Nakajima J; Fukayama M Int J Clin Exp Pathol; 2015; 8(11):15375-80. PubMed ID: 26823897 [TBL] [Abstract][Full Text] [Related]
23. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma. Luther C; Poeschel S; Varga M; Melms A; Tolosa E J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045 [TBL] [Abstract][Full Text] [Related]
25. Potential role of thymoma and other mediastinal tumors in the pathogenesis of myasthenia gravis. Matsui M; Wada H; Ohta M; Kuroda Y J Neuroimmunol; 1993 May; 44(2):171-6. PubMed ID: 8505406 [TBL] [Abstract][Full Text] [Related]
26. Epitopes expressed in myasthenia gravis (MG) thymomas are not recognized by patients' T cells or autoantibodies. Nagvekar N; Jacobson LW; Willcox N; Vincent A Clin Exp Immunol; 1998 Apr; 112(1):17-20. PubMed ID: 9566784 [TBL] [Abstract][Full Text] [Related]
28. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms. Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864 [TBL] [Abstract][Full Text] [Related]
29. Lymphocytes in thymomas are tolerant to self-MHC. Fujii Y; Okumura M; Inada K; Nakahara K Cell Immunol; 1991 Oct; 137(2):438-47. PubMed ID: 1832586 [TBL] [Abstract][Full Text] [Related]
30. The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis. Chuang WY; Ströbel P; Belharazem D; Rieckmann P; Toyka KV; Nix W; Schalke B; Gold R; Kiefer R; Klinker E; Opitz A; Inoue M; Kuo TT; Müller-Hermelink HK; Marx A Genes Immun; 2009 Dec; 10(8):667-72. PubMed ID: 19693092 [TBL] [Abstract][Full Text] [Related]
31. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma. Reinhardt C; Melms A Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443 [TBL] [Abstract][Full Text] [Related]
32. Different age-related effects of thymectomy in myasthenia gravis: role of thymoma, zinc, thymulin, IL-2 and IL-6. Mocchegiani E; Giacconi R; Muzzioli M; Gasparini N; Provinciali L; Spazzafumo L; Licastro F Mech Ageing Dev; 2000 Aug; 117(1-3):79-91. PubMed ID: 10958925 [TBL] [Abstract][Full Text] [Related]
33. [Expression of CD20 in thymomas and its clinical implication]. Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589 [TBL] [Abstract][Full Text] [Related]
34. Myasthenia gravis induces the activation and maturation of lymphocytes in thymoma. Takahashi K; Monden Y; Saito S; Kamamura Y; Uyama T J Clin Immunol; 1996 Jul; 16(4):190-7. PubMed ID: 8840220 [TBL] [Abstract][Full Text] [Related]
35. Regulation of Th-POK and Runx3 in T cell development in human thymoma. Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737 [TBL] [Abstract][Full Text] [Related]
36. Flow cytometric study of lymphocytes associated with thymoma and other thymic tumors. Fujii Y; Okumura M; Yamamoto S J Surg Res; 1999 Apr; 82(2):312-8. PubMed ID: 10090845 [TBL] [Abstract][Full Text] [Related]
37. Mature CD4 single positive thymocytes in human Thymoma: T cells may differentiate in the thymic epithelial cell tumor. Inoue M; Fujii Y; Okumura M; Takeuchi Y; Shiono H; Miyoshi S; Matsuda H; Shirakura R Pathobiology; 1997; 65(4):216-22. PubMed ID: 9396046 [TBL] [Abstract][Full Text] [Related]
38. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors. Chan JK; Tsang WY; Seneviratne S; Pau MY Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670 [TBL] [Abstract][Full Text] [Related]
39. Immaturity of lymphocytes in the metastatic lesions of thymoma. Inoue M; Okumura M; Fujii Y; Miyoshi S; Shiono H; Fukuhara K; Kadota Y; Matsuda H Clin Immunol Immunopathol; 1998 Sep; 88(3):249-55. PubMed ID: 9743611 [TBL] [Abstract][Full Text] [Related]
40. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes. Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A Front Immunol; 2020; 11():664. PubMed ID: 32373124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]